10-QPeriod: Q1 FY2020

3M CO Quarterly Report for Q1 Ended Mar 31, 2020

Filed April 28, 2020For Securities:MMM

Summary

3M Company's first quarter 2020 earnings showed a significant increase in net income and diluted EPS compared to the prior year, driven by a strong performance in the Health Care and Consumer segments, and bolstered by increased demand for personal safety products amid the COVID-19 pandemic. However, this was partially offset by softness in the Transportation and Electronics segment and increased litigation-related charges. Despite revenue growth, the company incurred charges related to COVID-19 impacts and asset write-downs, affecting adjusted earnings per share. Liquidity remains strong, supported by operating cash flow and access to capital markets. The company took proactive measures to preserve cash, including suspending its share repurchase program and reducing capital expenditure guidance for 2020. Management is actively monitoring the evolving COVID-19 situation and its potential impacts on supply chains, demand, and overall financial performance.

Financial Statements
Beta
Revenue$8.07B
Cost of Revenue$4.11B
Gross Profit$3.97B
SG&A Expenses$1.77B
Operating Expenses$6.41B
Operating Income$1.66B
Interest Expense$123.00M
Net Income$1.31B
EPS (Basic)$2.27
EPS (Diluted)$2.25
Shares Outstanding (Basic)576.80M
Shares Outstanding (Diluted)581.50M

Key Highlights

  • 1Net income increased by 45.0% to $1,292 million ($2.22 per diluted share) in Q1 2020, compared to $891 million ($1.51 per diluted share) in Q1 2019.
  • 2Total sales increased by 2.7% to $8,075 million in Q1 2020, with organic local-currency sales growing by 0.3%.
  • 3The Health Care segment saw a significant sales increase of 21.0% to $2,103 million, driven by acquisitions and organic growth, though operating income saw a slight decrease.
  • 4The Consumer segment also reported robust sales growth of 4.6% to $1,256 million, with improved operating income.
  • 5The Safety and Industrial segment's sales saw a slight decrease of 1.0% to $2,935 million, but operating income increased by 14.0% due to productivity improvements and higher respirator demand.
  • 6The company experienced a 5.0% decrease in sales for the Transportation and Electronics segment, totaling $2,238 million, impacted by global automotive builds and channel inventory adjustments.
  • 73M's financial position remains strong, with $4.5 billion in cash, cash equivalents, and marketable securities. The company suspended its share repurchase program due to COVID-19 uncertainty and reduced its 2020 capital expenditure forecast.

Frequently Asked Questions

3M reported a strong increase in net income and diluted earnings per share for the first quarter of 2020 compared to the prior year. Total sales also increased, driven by higher demand in certain segments like Personal Safety due to COVID-19 and growth in the Health Care and Consumer segments, though the Transportation and Electronics segment experienced a decline.

The COVID-19 pandemic had a mixed impact. It significantly increased demand for products like respirators and cleaning solutions, boosting sales in the Safety and Industrial segment. However, it also led to decreased demand in other markets such as oral care and automotive, and affected supply chains. The company also incurred charges related to COVID-19 impacted asset write-downs.

3M maintains a strong liquidity position with substantial cash reserves. In response to COVID-19 uncertainty, the company suspended its share repurchase program, reduced its capital expenditure forecast for 2020, and issued $1.75 billion in new debt in March 2020 to further bolster its cash position.

The filing details ongoing litigation and potential liabilities related to respirators/asbestos, various perfluorinated compounds (PFAS) manufacturing operations, product liability claims (Bair Hugger warming system, Combat Arms earplugs), and securities litigation. Accruals have been made for some of these matters, but many remain uncertain and could materially impact future results if adverse outcomes occur.